We are live on ! Find out more
VCIM

Velan Capital Investment Management Portfolio holdings

AUM $160M
1-Year Est. Return 517.12%
This Fund
S&P 500
This Quarter Est. Return
+52.62%
1 Year Est. Return
+517.12%
3 Year Est. Return
+2,524.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$117M
AUM Growth
+$4.12M
Cap. Flow
+$13.5M
Cap. Flow %
11.54%
Top 10 Hldgs %
77.49%
Holding
42
New
14
Increased
5
Reduced
2
Closed
11

Top Buys

Rank Stock Value
1
JSPR icon
Jasper Therapeutics
JSPR
+$14.8M
2
PRAX icon
Praxis Precision Medicines
PRAX
+$14.6M
3
HRTX icon
Heron Therapeutics
HRTX
+$5.01M
4
CABA icon
Cabaletta Bio
CABA
+$2.34M
5
GRTX
Galera Therapeutics, Inc. Common Stock
GRTX
+$2.06M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$7.83M
2
INSP icon
Inspire Medical Systems
INSP
+$2.52M
3
IMTX icon
Immatics
IMTX
+$2.18M
4
HCSG icon
Healthcare Services Group
HCSG
+$1.53M
5
SGEN
Seagen Inc. Common Stock
SGEN
+$1.29M

Sector Composition

Rank Sector Weight
1 Healthcare 96.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JSPR icon
1
Jasper Therapeutics
JSPR
$26.6M
$19.6M 16.72%
1,121,904
+800,000
+249% +$14.8M
ADMA icon
2
ADMA Biologics
ADMA
$2.18B
$13.2M 11.29%
4,000,000
– –
LNTH icon
3
Lantheus
LNTH
$6.59B
$12.4M 10.56%
150,000
– –
IMCR icon
4
Immunocore
IMCR
$1.73B
$9.89M 8.43%
200,000
-5,974
-3% -$336K
TELA icon
5
TELA Bio
TELA
$41.6M
$7.94M 6.77%
746,087
– –
HRTX icon
6
Heron Therapeutics
HRTX
$63.4M
$6.79M 5.79%
4,500,000
+2,000,000
+80% +$5.01M
OPTN
7
DELISTED
OptiNose
OPTN
$6.75M 5.75%
233,124
– –
QIPT
8
DELISTED
Quipt Home Medical
QIPT
$5.61M 4.78%
800,000
– –
FEZ icon
9
PUT
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.54B
$4.49M 3.83%
+100,000
New +$4.3M
PRAX icon
10
Praxis Precision Medicines
PRAX
$10.2B
$4.19M 3.58%
+345,667
New +$14.6M
PNT
11
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$3.59M 3.06%
494,136
– –
CTLT
12
DELISTED
CATALENT, INC.
CTLT
$3.29M 2.8%
50,000
– –
THC icon
13
Tenet Healthcare
THC
$20.9B
$3.08M 2.63%
51,900
+1,900
+4% +$106K
GRTX
14
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$2.56M 2.18%
+1,000,000
New +$2.06M
CABA icon
15
Cabaletta Bio
CABA
$457M
$2.07M 1.76%
+250,000
New +$2.34M
ETNB
16
DELISTED
89bio
ETNB
$1.5M 1.28%
+98,500
New +$1.28M
TERN
17
DELISTED
Terns Pharmaceuticals
TERN
$1.42M 1.21%
120,000
+109,354
+1,027% +$1.05M
IOVA icon
18
Iovance Biotherapeutics
IOVA
$2.9B
$1.34M 1.15%
+220,000
New +$1.52M
EDSA icon
19
Edesa Biotech
EDSA
$50.5M
$1.17M 1%
183,088
+56,104
+44% +$586K
THRX
20
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$888K 0.76%
+100,000
New +$981K
ICVX
21
DELISTED
Icosavax, Inc. Common Stock
ICVX
$870K 0.74%
+150,000
New +$1.3M
RZLT icon
22
Rezolute
RZLT
$451M
$768K 0.65%
400,000
– –
GERN icon
23
Geron
GERN
$949M
$651K 0.55%
+300,000
New +$852K
SNDA icon
24
Sonida Senior Living
SNDA
$1.99B
$562K 0.48%
82,832
– –
ALIM
25
DELISTED
Alimera Sciences
ALIM
$541K 0.46%
257,753
– –
1
2

Similar funds

BFAG
Blackston Financial Advisory Group The Villages, Florida $160M AUM 16.38% 1-Year Est. Return
SLG
Sanchez Levi Garrett $159M AUM
SMF
Sterling Manor Financial Saratoga Springs, New York $160M AUM 13.84% 1-Year Est. Return
LCA
Legend Capital Advisors New York $160M AUM
SA
swisspartners Advisors Zurich, Switzerland $159M AUM 36.51% 1-Year Est. Return
SGCM
Sanchez Gaunt Capital Management Reno, Nevada $160M AUM
RP
RIHO Partners Tucson, Arizona $159M AUM
PCC
Perry Creek Capital New York $160M AUM 3.05% 1-Year Est. Return

Velan Capital Investment Management's Q1 2023 Portfolio in Review

As of Q1 2023, Velan Capital Investment Management held 42 positions worth $117M, up 3.6% from $113M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Velan Capital Investment Management deployed $13.5M of net new capital in Q1 2023, opening 14 new positions and adding to 5 existing holdings. Its largest new stake was Praxis Precision Medicines: 345,667 shares worth $4.19M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 83% a quarter earlier.

On the sell side, the largest reduction was Collegium Pharmaceutical, an estimated $593K trimmed.

  • Velan Capital Investment Management's largest Q1 2023 buy was Praxis Precision Medicines: 345,667 shares worth $4.19M.
  • Velan Capital Investment Management added most to Jasper Therapeutics in Q1 2023, an estimated $14.8M increase.
  • Velan Capital Investment Management's biggest Q1 2023 reduction was Collegium Pharmaceutical, cutting an estimated $593K.
  • Velan Capital Investment Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, selling an estimated $7.83M.
  • Velan Capital Investment Management's ten largest holdings make up 77% of its $117M portfolio in Q1 2023.
  • Velan Capital Investment Management opened 14 new positions and closed 11 in Q1 2023.
  • Velan Capital Investment Management's portfolio value rose 3.6% quarter-over-quarter to $117M.

Based on Velan Capital Investment Management's 13F filing for Q1 2023, filed 15 May 2023.